New kidney drug candidate tested for drug interactions in healthy volunteers
NCT ID NCT07565441
First seen May 08, 2026 · Last updated May 08, 2026
Summary
This early-stage study tests a new tablet called JMKX003142 in 112 healthy Chinese adults to see how it interacts with other common drugs. The goal is to understand how the body processes the drug and whether it affects or is affected by other medications. This information will help guide future studies for treating polycystic kidney disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADPKD (AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.